JP2001318095A5 - - Google Patents

Download PDF

Info

Publication number
JP2001318095A5
JP2001318095A5 JP2000135043A JP2000135043A JP2001318095A5 JP 2001318095 A5 JP2001318095 A5 JP 2001318095A5 JP 2000135043 A JP2000135043 A JP 2000135043A JP 2000135043 A JP2000135043 A JP 2000135043A JP 2001318095 A5 JP2001318095 A5 JP 2001318095A5
Authority
JP
Japan
Prior art keywords
opioid
disease
pruritus
measured
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000135043A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001318095A (ja
JP4370683B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2000135043A priority Critical patent/JP4370683B2/ja
Priority claimed from JP2000135043A external-priority patent/JP4370683B2/ja
Priority to US09/704,319 priority patent/US6984493B1/en
Priority to CA002324982A priority patent/CA2324982A1/en
Publication of JP2001318095A publication Critical patent/JP2001318095A/ja
Publication of JP2001318095A5 publication Critical patent/JP2001318095A5/ja
Application granted granted Critical
Publication of JP4370683B2 publication Critical patent/JP4370683B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000135043A 2000-05-08 2000-05-08 そう痒疾患の検査方法 Expired - Fee Related JP4370683B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2000135043A JP4370683B2 (ja) 2000-05-08 2000-05-08 そう痒疾患の検査方法
US09/704,319 US6984493B1 (en) 2000-05-08 2000-11-02 Method for examining the involvement of opioid peptides in prurtis
CA002324982A CA2324982A1 (en) 2000-05-08 2000-11-02 Method for examining disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000135043A JP4370683B2 (ja) 2000-05-08 2000-05-08 そう痒疾患の検査方法

Publications (3)

Publication Number Publication Date
JP2001318095A JP2001318095A (ja) 2001-11-16
JP2001318095A5 true JP2001318095A5 (cg-RX-API-DMAC7.html) 2007-10-18
JP4370683B2 JP4370683B2 (ja) 2009-11-25

Family

ID=18643206

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000135043A Expired - Fee Related JP4370683B2 (ja) 2000-05-08 2000-05-08 そう痒疾患の検査方法

Country Status (3)

Country Link
US (1) US6984493B1 (cg-RX-API-DMAC7.html)
JP (1) JP4370683B2 (cg-RX-API-DMAC7.html)
CA (1) CA2324982A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005011113D1 (de) * 2004-03-30 2009-01-02 Toray Industries Morphinanderivate als mittel gegen juckreiz
KR101334401B1 (ko) 2006-04-11 2013-11-29 한국생명공학연구원 아토피 피부 질환의 기전을 모니터링 할 수 있는 아토피피부 질환의 진단 또는 치료용 마커 단백질
KR101257307B1 (ko) 2006-05-22 2013-04-23 한국생명공학연구원 인간 혈청 프로테옴에서 발굴한 아토피 피부 질환의 기전을모니터링 할 수 있는 아토피 피부 질환의 진단 또는치료용 마커 단백질
WO2011049433A1 (en) * 2009-10-23 2011-04-28 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Diagnosis and treatment of pruritis
US20140066475A1 (en) 2012-09-04 2014-03-06 Euro-Celtique S.A. Method For Treating Pruritus
US8637538B1 (en) 2012-12-14 2014-01-28 Trevi Therapeutics, Inc. Methods for treatment of pruritis
US20140179727A1 (en) 2012-12-14 2014-06-26 Trevi Therapeutics, Inc. Methods for treating pruritus
US8987289B2 (en) 2012-12-14 2015-03-24 Trevi Therapeutics, Inc. Methods for treating pruritus
KR20150003059A (ko) * 2013-06-28 2015-01-08 김종배 뇨 중 글리아돌핀(Gliadorphin) 농도 측정을 위한 면역분석법
CA3091752A1 (en) 2018-03-08 2019-09-12 Victoria Link Ltd Treatment of demyelinating diseases
CN118512451A (zh) 2018-07-23 2024-08-20 特雷维治疗股份有限公司 慢性咳嗽、呼吸急促和呼吸困难的治疗
IL294601A (en) 2020-01-10 2022-09-01 Trevi Therapeutics Inc Methods of administration of nalbuphine

Similar Documents

Publication Publication Date Title
Pinzani et al. Liver cirrhosis
Noori et al. Survival predictability of lean and fat mass in men and women undergoing maintenance hemodialysis
Whicher et al. When is serum albumin worth measuring?
WO2005010213A3 (en) Markers for detection of gastric cancer
WO2000052463A1 (en) Method of diagnosing and monitoring malignant breast carcinomas
WO2004039244A3 (en) Methods and kits for diagnosing tumorigenicity
Toering et al. Higher filtration fraction in formerly early-onset preeclamptic women without comorbidity
Drayer et al. Low and high renin essential hypertension: a comparison of clinical and biochemical characteristics
Borowsky et al. Elevation of serum angiotensin-converting enzyme level: occurrence in alcoholic liver disease
Davenport et al. Hydration status does not influence peritoneal equilibration test ultrafiltration volumes
Gallardo et al. Increased plasma levels of atrial natriuretic peptide and endocrine markers of volume depletion in patients with obstructive jaundice
JP4370683B2 (ja) そう痒疾患の検査方法
JP2004513074A5 (cg-RX-API-DMAC7.html)
Akarsu et al. Relation between serum ubiquitin levels and KT/V in chronic hemodialysis patients
Krediet et al. The physiology and pathophysiology of peritoneal transport
WO2002072752A3 (en) Forms of prostate specific antigens and methods for their detection
Mori et al. Close correlation of liver stiffness with collagen deposition and presence of myofibroblasts in non‐alcoholic fatty liver disease
DK1263381T3 (da) Dametrusseindlæg, især til gravide
JP2000214163A5 (cg-RX-API-DMAC7.html)
Corvol Tumor-dependent hypertension.
CN216394117U (zh) 一种医疗检测用尿液取样装置
CN206177965U (zh) 一种测定早孕结果的试纸
CN205691597U (zh) 一种可拆酶标板
Tzamaloukas et al. Adequacy of continuous ambulatory peritoneal dialysis
Degoricija et al. Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial